Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Access Medical Labs will run the Siemens Health FDA Authorized reagent under their EUA at its State of the Art Facility in Jupiter, FL.
read more
Seven Bridges announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer.
read more
Celerion announced the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities.
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
Ryvu Therapeutics has signed a grant agreement with the National Centre for Research and Development for the development of targeted immuno-oncology therapy.
read more
Novadoz has received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.
read more
Intravacc and Versatope have signed a research service agreement to further develop a universal vaccine against influenza based on Intravacc’s OMV technology.
read more
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO.
read more
The FDA and the NTIA are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online.
read more
CGT Catapult announced Achilles will manufacture their advanced therapy products for clinical trials in one of the newly operational modules at the CGT Catapult manufacturing center.
read more
Marksans Pharma Limited, India is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets, USP 500mg, lot # XP9004, to the consumer level.
read more
Molecule Holdings (MH) has secured North American distribution for one of the first COVID-19 IgM/IgG Antibody Rapid Tests to receive FDA/EUA approval.
read more
Panacea Biotec has announced a collaboration with Refana USA to make COVID-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland.
read more